Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 189 | 61 | 1,406 | 881 | 4,417 |
| Receivables | 88 | 194 | 305 | 272 | 219 |
| TOTAL | $373 | $364 | $2,049 | $1,509 | $4,753 |
| Non-Current Assets | |||||
| PPE Net | 13 | 69 | 189 | 207 | 220 |
| Other Non-Current Assets | 160 | 230 | 489 | 530 | 557 |
| TOTAL | $173 | $299 | $677 | $737 | $777 |
| Total Assets | $546 | $663 | $2,726 | $2,247 | $5,530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,040 | 15,032 | 13,931 | 14,932 | 14,631 |
| TOTAL | $17,703 | $17,732 | $16,409 | $15,010 | $14,705 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 745 | 686 | 568 | 0 | 0 |
| TOTAL | $745 | $710 | $856 | $321 | $344 |
| Total Liabilities | $18,448 | $18,442 | $17,265 | $15,331 | $15,050 |
| Shareholders' Equity | |||||
| Common Shares | 84,738 | 85,916 | 83,082 | 86,164 | 85,725 |
| Retained earnings | -118,581 | -119,274 | -112,474 | -113,889 | -110,469 |
| Other shareholders' equity | 384 | 322 | 320 | 25 | 25 |
| TOTAL | $-17,902 | $-17,780 | $-14,539 | $-13,084 | $-9,519 |
| Total Liabilities And Equity | $546 | $663 | $2,726 | $2,247 | $5,530 |